Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [13558]

The dawn of RAS-targeted therapy: a landmark breakthrough of daraxonrasib in pancreatic cancer

The dawn of RAS-targeted therapy: a landmark breakthrough of daraxonrasib in pancreatic cancer

Making invisible cancers visible: Study suggests a new route to turn ‘cold’ tumours ‘hot’

Making invisible cancers visible: Study suggests a new route to turn ‘cold’ tumours ‘hot’

Study uncovers genomic architecture and natural history of metastatic bladder cancer

Study uncovers genomic architecture and natural history of metastatic bladder cancer

Study finds mindfulness and tai chi practices eased sleep problems, fatigue, and pain after cancer treatment

Study finds mindfulness and tai chi practices eased sleep problems, fatigue, and pain after cancer treatment

Cancer biologists are bringing in the B cell reinforcements

Cancer biologists are bringing in the B cell reinforcements

mTORC1 inhibition could enhance CD20-targeted therapy in B-cell precursor ALL

mTORC1 inhibition could enhance CD20-targeted therapy in B-cell precursor ALL

UK’s NICE approves trastuzumab deruxtecan for HER2-low metastatic breast cancer

UK’s NICE approves trastuzumab deruxtecan for HER2-low metastatic breast cancer

Why some cancer patients respond to immunotherapy while others don’t may depend on what happens early in treatment

Why some cancer patients respond to immunotherapy while others don’t may depend on what happens early in treatment

First clinical guideline on radiation therapy for bladder cancer issued

First clinical guideline on radiation therapy for bladder cancer issued

WCLC 2026: MRI surveillance reduces cognitive decline compared with prophylactic cranial irradiation in SCLC

WCLC 2026: MRI surveillance reduces cognitive decline compared with prophylactic cranial irradiation in SCLC

More from ecancer